Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR101) Improve Event-Free Survival (GRFS) and Overall Survival in a T-Cell Depleted Haploidentical HSCT: Phase 2 Trial in Patients with AML and ALL - Roy, Denis-Claude; Lachance, Silvy; Roy, Jean; Walker, Irwin; Maertens, Johan; Delisle, Jean-Sebastien; Foley, Stephen Ronan; Lewalle, Philippe; Olavarria, Eduardo; Selleslag, Dominik; Rüdiger, Manfred; Velthuis, Jurjen; et al. (Blood, 2016)